[Molecular Diagnostics and Personalized Therapy for Metastatic Castration-Resistant Prostate Cancer (mCRPC)].

Published 09/16/2026

Research record: [Molecular Diagnostics and Personalized Therapy for Metastatic Castration-Resistant Prostate Cancer (mCRPC)].

Published in Aktuelle Urol; first publication date 2026-09-16. PMID 42748971.

This literature update records publication metadata from Europe PMC. Consult the original publication for its methods, findings and limitations.

Review and references

Source

Compiled from public manufacturer materials and regulatory sources. Not independently verified and not reviewed by a named clinician.

Published

2026-09-16

Updated

2026-10-19

Disclaimer

professional use

References